Cornercap Investment Counsel Inc. acquired a new stake in Campbell Soup (NYSE:CPB) during the 1st quarter, HoldingsChannel.com reports. The fund acquired 63,350 shares of the company’s stock, valued at approximately $2,744,000.
A number of other large investors have also added to or reduced their stakes in the stock. Bank of New York Mellon Corp boosted its stake in Campbell Soup by 0.3% in the fourth quarter. Bank of New York Mellon Corp now owns 6,513,912 shares of the company’s stock valued at $313,384,000 after buying an additional 20,720 shares in the last quarter. Schroder Investment Management Group boosted its stake in Campbell Soup by 29.7% in the fourth quarter. Schroder Investment Management Group now owns 4,619,380 shares of the company’s stock valued at $222,238,000 after buying an additional 1,058,752 shares in the last quarter. Geode Capital Management LLC boosted its stake in Campbell Soup by 2.8% in the fourth quarter. Geode Capital Management LLC now owns 2,520,032 shares of the company’s stock valued at $121,039,000 after buying an additional 67,987 shares in the last quarter. Champlain Investment Partners LLC acquired a new stake in Campbell Soup in the first quarter valued at about $56,667,000. Finally, Guggenheim Capital LLC boosted its stake in Campbell Soup by 23.7% in the fourth quarter. Guggenheim Capital LLC now owns 1,206,442 shares of the company’s stock valued at $58,042,000 after buying an additional 231,178 shares in the last quarter. 48.66% of the stock is currently owned by institutional investors and hedge funds.
Hot Value Stocks To Invest In 2019: Century Aluminum Company(CENX)
- [By Alexander Bird]
Aluminum producer Century Aluminum Co. (Nasdaq: CENX) added 3.3%to its share price, and Alcoa Corp. (NYSE: AA) edged up 0.2%, both closing out the day with gains.
- [By D.R. Barton, Jr.]
According to industry leaders, including Century Aluminum Co. (Nasdaq: CENX) CEO Michael Bless, many of those jobs will be in jeopardy with the new taxes. And then there’s the reciprocal tariff reactions from other nations that would definitely hit the billions of dollars’ worth of U.S. agricultural exports with further jobs in jeopardy.
- [By Jon C. Ogg]
Century Aluminum Co. (NASDAQ: CENX) was last seen up 16 cents at $14.97, but its 52-week range is $12.94 to $24.77. Its shares have a consensus analyst target of $22.80, and this traded at nearly $18 at the start of June.
- [By Rich Smith]
Shares of Century Aluminum (NASDAQ:CENX)are off 9.7% as of 11 a.m. EDT despite the company reporting a sizable earnings “beat” this morning. Instead of posting expected pro forma losses of $0.23 per share for its fiscal first-quarter 2018, its loss for the quarter was less than $0.01 per share ($0.04 after adjusting for one-time items).
- [By Matthew DiLallo]
Shares of aluminum producers Century Aluminum Co. (NASDAQ:CENX) and Alcoa Corp. (NYSE:AA) tumbled on Thursday, falling more than 10% and 13%, respectively, by 2:30 p.m. EDT. Driving the decline was Alcoa’s second-quarter earnings report, which detailed a “significant” impact from aluminum tariffs instituted this year.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent
Hot Value Stocks To Invest In 2019: Jazz Pharmaceuticals Inc.(JAZZ)
- [By Max Byerly]
Here are some of the news headlines that may have impacted Accern’s rankings:
Get Jazz Pharmaceuticals alerts:
Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sle… (advfn.com) Jazz Pharmaceuticals (JAZZ) Given a $194.00 Price Target at Royal Bank of Canada (americanbankingnews.com) Analyzing Jazz Pharmaceuticals (JAZZ) & Celyad (CYAD) (americanbankingnews.com) Global Marine Pharmaceuticals Market Growing at a CAGR of 7.28% to 2022 (empowerednews.net) Physicians Unaware of Neurologic Effects Related to Obstructive Sleep Apnea, Finds Jazz Pharmaceuticals Survey (sleepreviewmag.com)
Shares of Jazz Pharmaceuticals traded up $1.75, hitting $170.75, during trading on Friday, MarketBeat reports. 928,650 shares of the company were exchanged, compared to its average volume of 466,308. The firm has a market capitalization of $10.11 billion, a price-to-earnings ratio of 17.86, a price-to-earnings-growth ratio of 0.87 and a beta of 0.97. Jazz Pharmaceuticals has a fifty-two week low of $128.58 and a fifty-two week high of $171.76. The company has a quick ratio of 2.88, a current ratio of 3.00 and a debt-to-equity ratio of 0.55.
- [By Shane Hupp]
Private Capital Advisors Inc. acquired a new position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) during the second quarter, HoldingsChannel reports. The institutional investor acquired 24,200 shares of the specialty pharmaceutical company’s stock, valued at approximately $4,170,000.
- [By Keith Speights]
But at least three of the biotechs singled out by the FDA deserve to be on another list — investors’ buy lists. Here’s why Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Jazz Pharmaceuticals (NASDAQ:JAZZ) look like great stock picks right now.
- [By Lisa Levin]
Companies Reporting After The Bell
Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion.
Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion.
The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion.
Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million.
Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion.
LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion.
Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion.
TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million.
The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million.
A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion.
Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million.
Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million.
ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million.
KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13
- [By Logan Wallace]
Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot Value Stocks To Invest In 2019: Regis Corporation(RGS)
- [By Max Byerly]
JPMorgan Chase & Co. reduced its position in shares of Regis Co. (NYSE:RGS) by 4.0% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,065,983 shares of the company’s stock after selling 44,497 shares during the quarter. JPMorgan Chase & Co. owned about 2.31% of Regis worth $16,128,000 as of its most recent SEC filing.
- [By Stephan Byrd]
Shares of Regis Co. (NYSE:RGS) have been given an average rating of “Buy” by the six ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $18.00.
- [By Stephan Byrd]
Regis Co. (NYSE:RGS) reached a new 52-week high and low during trading on Wednesday . The stock traded as low as $17.50 and last traded at $17.50, with a volume of 3726 shares changing hands. The stock had previously closed at $17.43.